Improving our understanding of ependymomas in the spinal cord
Comprehensive molecular characterization of paediatric spinal ependymomas
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Comprehensive molecular characterization of paediatric spinal ependymomas
Ordering of driver mutations in bilateral Wilms’ tumour
Histopathology of lymphomas in children with primary immune deficiency
Developing leukaemic biomarkers to enable personalised CNS-directed therapy
Improving the diagnosis of children’s brain tumours by Functional Radiomics
Investigating the arginine auxotrophy of paediatric brain tumours
Epigenetic deregulation of splicing in childhood renal malignancies
Testing the use of mebendazole and albendazole for children with acute myeloid leukaemia, and investigating how the drugs work.
Screening for novel drug combinations in childhood B-cell acute lymphoblastic leukaemia